At Heligenics, we produce all genetic variants for a given gene and test how all those variants functionally impact, en masse, live human cells.
We are the first company to enable High Content Screening for Biologics
.png){kind=logo}
™
Biotechnology & Pharmaceuticals
Heligenics is disrupting and redefining the way new drugs are created by using genetic information at each step along the drug development pipeline. Use our MEGA-Map™ pre-clinically to identify resistance mutations and eliminate many non-responders before an expensive clinical trial. Our super-precision genetic-based trial design increases efficacy and reduces project risk. Redesign a failed conventional trial into a targeted precision trial. Our GigaAssay™ technology can be used to design, develop, and test multiple Biosimilar or Biobetter leads.
​
Drug development is a risky endeavor.
What if a higher percentage of these drugs or derivatives could be brought to market or if you could increase revenue from new markets? Heligenics offers 4 new products at different stages of the drug development pipeline.
Our Pharma and Biotech Solutions
This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors.
